LLY
805.71
-1.45%↓
UNH
556.95
-1.68%↓
JNJ
158.12
-1.16%↓
NVO
109.92
-1.81%↓
ABBV
200.71
-1.24%↓
LLY
805.71
-1.45%↓
UNH
556.95
-1.68%↓
JNJ
158.12
-1.16%↓
NVO
109.92
-1.81%↓
ABBV
200.71
-1.24%↓
LLY
805.71
-1.45%↓
UNH
556.95
-1.68%↓
JNJ
158.12
-1.16%↓
NVO
109.92
-1.81%↓
ABBV
200.71
-1.24%↓
LLY
805.71
-1.45%↓
UNH
556.95
-1.68%↓
JNJ
158.12
-1.16%↓
NVO
109.92
-1.81%↓
ABBV
200.71
-1.24%↓
LLY
805.71
-1.45%↓
UNH
556.95
-1.68%↓
JNJ
158.12
-1.16%↓
NVO
109.92
-1.81%↓
ABBV
200.71
-1.24%↓
Overview
Share price change
24h
Current
Min
0.6
Max
0.62
Next Earnings | 11 Nov 2024 |
|---|
Technical Score
By Trading Central
Confidence
Weak Bearish Evidence
1.67 / 2.05 Support & Resistance
Cyclacel Pharmaceuticals Inc Chart
Past performance is not a reliable indicator of future results.
Related News
1 Nov 2024, 22:50 UTC
Stocks to Watch: Nvidia, Intel, Sherwin-Williams, Dow, Nuwellis
DJ
Read
1 Nov 2024, 22:43 UTC
Nvidia, Sherwin-Williams Shares Up on Addition to DJIA
DJ
Read
1 Nov 2024, 22:13 UTC
Chewy Up 5% on S&P MidCap 400 Inclusion
DJ
Read
1 Nov 2024, 21:39 UTC
Insurance Company Chubb Projects Up to $300 Million Pre-Tax Loss on Hurricane
DJ
Read
2 Nov 2024, 13:53 UTC
Warren Buffett's Berkshire Hathaway Slashes Apple Stake Again -- Update
DJ
Read
2 Nov 2024, 13:44 UTC
Berkshire Sold 25% of Its Apple Stock in the Third Quarter -- Barrons.com
DJ
Read
2 Nov 2024, 13:00 UTC
China's EV Makers Set Sights on Latin America in Global Expansion -- WSJ
DJ
Read
2 Nov 2024, 12:58 UTC
Berkshire Sold 25% of Its Apple Stock in the Third Quarter -- Barrons.com
DJ
Read
2 Nov 2024, 12:48 UTC
Warren Buffett's Berkshire Hathaway Slashes Apple Stake Again -- WSJ
DJ
Read
2 Nov 2024, 12:32 UTC
Berkshire Profits Fell 6% in Third Quarter. The Buybacks Are on Pause. -- Barrons.com
DJ
Read
2 Nov 2024, 12:28 UTC
Berkshire Sold 25% of Its Apple Stock in the Third Quarter -- Barrons.com
DJ
Read
2 Nov 2024, 12:17 UTC
Berkshire Profits Fell 6% in Third Quarter. The Buybacks Are on Pause. -- Barrons.com
DJ
Read
2 Nov 2024, 12:00 UTC
Berkshire Hathaway 3Q EPS $18272.00 >BRKA
DJ
Read
2 Nov 2024, 12:00 UTC
Berkshire Hathaway 3Q BNSF Operating Earnings $1.38B >BRKA
DJ
Read
2 Nov 2024, 12:00 UTC
Berkshire Hathaway 3Q Berkshire Hathaway Energy Company Operating Earnings $1.63B >BRKA
DJ
Read
2 Nov 2024, 12:00 UTC
Berkshire Hathaway 3Q Insurance-Underwriting Operating Earnings $750M >BRKA
DJ
Read
2 Nov 2024, 12:00 UTC
Berkshire Hathaway 3Q Other Operating Loss $877M >BRKA
DJ
Read
2 Nov 2024, 12:00 UTC
Berkshire Hathaway 3Q Insurance-Investment Income Operating Earnings $3.66B >BRKA
DJ
Read
2 Nov 2024, 12:00 UTC
Berkshire Hathaway 3Q Net $26.25B >BRKA
DJ
Read
2 Nov 2024, 12:00 UTC
Berkshire Hathaway 3Q Other Controlled Businesses Operating Earnings $3.34B >BRKA
DJ
Read
2 Nov 2024, 12:00 UTC
Berkshire Hathaway 3Q Non-Controlled Businesses Operating Earnings $199M >BRKA
DJ
Read
2 Nov 2024, 12:00 UTC
Berkshire Hathaway 3Q Operating Earnings $10.09B >BRKA
DJ
Read
2 Nov 2024, 12:00 UTC
Berkshire Hathaway 3Q Investment, Derivative Gains $16.16B >BRKA
DJ
Read
2 Nov 2024, 09:30 UTC
Awful Jobs Report Aside, the Economy Is Still Strong -- Heard on the Street -- WSJ
DJ
Read
2 Nov 2024, 08:20 UTC
Tech, Media & Telecom Roundup: Market Talk
DJ
Read
2 Nov 2024, 08:20 UTC
Auto & Transport Roundup: Market Talk
DJ
Read
1 Nov 2024, 22:51 UTC
Correction to Nvidia to Replace Intel in Dow Jones Industrial Average Article -- WSJ
DJ
Read
1 Nov 2024, 22:00 UTC
Nvidia to Replace Intel in Dow Jones Industrial Average. Sherwin-Williams Also Joins. -- WSJ
DJ
Read
1 Nov 2024, 21:29 UTC
Exxon and Chevron Feel Brunt of Cheaper Oil -- 2nd Update
DJ
Read
1 Nov 2024, 21:24 UTC
Insurance Company Chubb Projects Up to $300M Pre-Tax Loss on Hurricane
DJ
Read
Peer Comparison
Price change
Cyclacel Pharmaceuticals Inc Forecast
Rating Consensus
By TipRanks
Neutral
1 ratings
0
Buy
1
Hold
0
Sell
Based on 1 analysts giving stock ratings to Cyclacel Pharmaceuticals Inc - Dist in the past 3 months.
Technical Score
By Trading Central
Short Term
Weak Bearish Evidence
Bearish events outweigh bullish events.
Intermediate Term
Weak Bullish Evidence
Recent bullish events outweigh bearish events.
Long Term
Weak Bearish Evidence
There is one bearish event.
Financials
$
